Although VEGF is primarily known for its role in promoting angiogenesis, there is mounting evidence that VEGF also has an immunosuppressive effect and that targeting tumor vasculature may increase the efficacy of immunotherapy. The gene discussed is VEGFA; the disease is neoplasm.